Dr. Robert Shafer, MD

Non-nucleoside reverse transcriptase inhibitor (NNRTI) cross-resistance

JOURL OF ANTIMICROBIAL CHEMOTHERAPY, 2014

Prototypical Recombint Multi-Protease

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013

Trends in Genotypic HIV-1 Antiretroviral Resistance between 2006

PLOS ONE, 2013

Nucleoside reverse transcriptase inhibitor resistance mutations associated with first

jourl of infectious diseases, 2013

Collinearity of protease mutations in HIV-1 samples with high

JOURL OF ANTIMICROBIAL CHEMOTHERAPY, 2013

Low-Level Persistence of Drug Resistance Mutations in Hepatitis B Virus

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013

Panel of Prototypical Recombint Infectious Molecular Clones Resistant to Nevirapine, Efavirenz

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012

A Review of the Virological Efficacy of the 4 World Health Organization-Recommended Tenofovir

CLINICAL INFECTIOUS DISEASES, 2012

HIV-1 Antiretroviral Resistance: Scientific Principles and Clinical Applications

DRUGS, 2012

The efficacy of an anti-CD4 monoclol antibody for HIV-1 treatment

ANTIVIRAL RESEARCH, 2011

HIV-1 Integrase Inhibitor Resistance and Its Clinical Implications

JOURL OF INFECTIOUS DISEASES, 2011

Comparison of the Mechanisms of Drug Resistance among HIV, Hepatitis B, and Hepatitis C

VIRUSES-BASEL, 2010

HIV-1 Protease Mutations and Protease Inhibitor Cross-Resistance

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010

Minority Variants Associated with Transmitted

JAIDS-JOURL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009

Nonpolymorphic Human Immunodeficiency Virus Type 1 Protease

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009

Predictive Value of HIV-1 Genotypic Resistance Test Interpretation Algorithms

JOURL OF INFECTIOUS DISEASES, 2009

Ultra-Deep Pyrosequencing of Hepatitis B Virus Quasispecies from Nucleoside

JOURL OF INFECTIOUS DISEASES, 2009

Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update

PLOS ONE, 2009

Low-Abundance Drug-Resistant HIV-1 Variants

JOURL OF INFECTIOUS DISEASES, 2009

A transitiol endogenous lentivirus from the genome of a basal primate

PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 2008

Characterization of mutation spectra with ultra-deep pyrosequencing

GENOME RESEARCH, 2007

HIV-1 subtype B protease and reverse transcriptase amino acid covariation

PLOS COMPUTATIOL BIOLOGY, 2007

Genotypic predictors of human immunodeficiency virus type 1 drug resistance

PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 2006

Ratiole and uses of a public HIV drug-resistance database

JOURL OF INFECTIOUS DISEASES, 2006

Web resources for HIV type 1 genotypic-resistance test interpretation

CLINICAL INFECTIOUS DISEASES, 2006

HIV-1 pol mutation frequency by subtype and treatment experience

AIDS, 2006

HIV-1 protease and reverse-transcriptase mutations

JOURL OF INFECTIOUS DISEASES, 2005

Drug resistance and antiretroviral drug development

JOURL OF ANTIMICROBIAL CHEMOTHERAPY, 2005

Panel of prototypical infectious molecular HIV

AIDS, 2005

Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype

PLOS MEDICINE, 2005

Comparison of four-drug regimens

NEW ENGLAND JOURL OF MEDICINE, 2003

Colinearity of reverse transcriptase inhibitor resistance mutations detected by population

JAIDS-JOURL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003

Lack of detectable human immunodeficiency virus type 1 superinfection during 1072 person

JOURL OF INFECTIOUS DISEASES, 2003

Extended spectrum of HIV

AIDS, 2003

Mutation patterns and structural correlates in human immunodeficiency virus type 1 protease

JOURL OF VIROLOGY, 2003

Human immunodeficiency virus reverse transcriptase and protease sequence database

NUCLEIC ACIDS RESEARCH, 2003

Genotypic testing for human immunodeficiency virus type 1 drug resistance

CLINICAL MICROBIOLOGY REVIEWS, 2002

Human immunodeficiency virus type 1 reverse transcriptase

TURE MEDICINE, 2000

HIV-1 genotypic resistance patterns predict response to saquivir

ANLS OF INTERL MEDICINE, 1999

Sequence and drug susceptibility of subtype C protease from human immunodeficiency virus type 1

AIDS RESEARCH AND HUMAN RETROVIRUSES, 1999

Multiple concurrent reverse transcriptase and protease mutations and multidrug resistance of HIV

ANLS OF INTERL MEDICINE, 1998

Sequence and drug susceptibility of subtype C reverse transcriptase from human immunodeficiency

JOURL OF VIROLOGY, 1997

Tuberculosis in patients infected with human immunodeficiency virus: Perspective on the past decade

CLINICAL INFECTIOUS DISEASES, 1996

Predictors of survival in HIV-infected tuberculosis patients

AIDS, 1996

TEMPORAL TRENDS AND TRANSMISSION PATTERNS DURING THE EMERGENCE OF MULTIDRUG

JOURL OF INFECTIOUS DISEASES, 1995

COMBITION THERAPY WITH ZIDOVUDINE AND DIDANOSINE SELECTS FOR DRUG-RESISTANT HUMAN

JOURL OF INFECTIOUS DISEASES, 1994

EXOGENOUS REINFECTION WITH MULTIDRUG-RESISTANT MYCOBACTERIUM

NEW ENGLAND JOURL OF MEDICINE, 1993

EXTRAPULMORY TUBERCULOSIS IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION

MEDICINE, 1991

HIV-1 fitness landscape models for indivir treatment pressure using observed evolution in

Infection, genetics and evolution : jourl of molecular epidemiology an, 2013

Drug Resistance Mutations in HIV-1.

Topics in HIV medicine : a publication of the Intertiol AIDS Society,

Cooperative Effects of Drug-Resistance Mutations in the Flap Region of HIV-1 Protease

ACS CHEMICAL BIOLOGY, 2013

Update of the drug resistance mutations in HIV-1: March 2013.

Topics in antiviral medicine, 2013

In vitro HIV-1 evolution in response to triple reverse transcriptase inhibitors & in silico

PloS one, 2013

T Cell Activation Markers

PLOS ONE, 2012

Development of Elvitegravir Resistance

PLOS ONE, 2012

Automating HIV Drug Resistance Genotyping with RECall, a Freely Accessible Sequence Alysis Tool

JOURL OF CLINICAL MICROBIOLOGY, 2012

Whole-genome sequencing of the efficient industrial fuel

MOLECULAR GENETICS AND GENOMICS, 2012

Standardized representation

AIDS RESEARCH AND THERAPY, 2012

Standardized Comparison of the Relative Impacts of HIV-1 Reverse Transcriptase

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012

The HIVdb System for HIV-1 Genotypic Resistance Interpretation

INTERVIROLOGY, 2012

A multifaceted alysis of HIV-1 protease multidrug resistance phenotypes

BMC BIOINFORMATICS, 2011

2011 update of the drug resistance mutations in HIV-1.

Topics in antiviral medicine, 2011

Loss of Protease Dimerization Inhibition Activity of Daruvir

JOURL OF VIROLOGY, 2011

Prediction of response to antiretroviral therapy by human experts

HIV MEDICINE, 2011

Hepatitis B virus reverse transcriptase sequence variant database for sequence alysis

ANTIVIRAL RESEARCH, 2010

A classification model for G-to

BIOINFORMATICS, 2010

HIV-1 Integrase Sequence Variability in Antiretroviral ive Patients

AIDS RESEARCH AND HUMAN RETROVIRUSES, 2010

Estimating the individualized HIV-1 genetic barrier to resistance using a nelfivir fitness l

BMC BIOINFORMATICS, 2010

Long-term increase in CD4

AIDS, 2010

Constrained patterns of covariation

JOURL OF ANTIMICROBIAL CHEMOTHERAPY, 2010

Nucleic Acid Template and the Risk of a PCR-Induced HIV-1 Drug Resistance Mutation

PLOS ONE, 2010

African Mitochondrial D Subhaplogroups and Peripheral Neuropathy during Antiretroviral Therapy

JOURL OF INFECTIOUS DISEASES, 2010

Predicting Tipravir and Daruvir Resistance Using Genotypic, Phenotypic

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010

Public database for HIV drug resistance in southern Africa

TURE, 2010

Panel of Prototypical Raltegravir-Resistant Infectious Molecular Clones in a Novel Integrase

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010

The calibrated population resistance tool

BIOINFORMATICS, 2009

Human Immunodeficiency Virus Type 1 Isolates with the Reverse Transcriptase

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009

Predicting the Response to Combition Antiretroviral Therapy

JOURL OF INFECTIOUS DISEASES, 2009

The challenge of antiretroviral drug resistance in HIV-1-infected children

JORL DE PEDIATRIA, 2009

Incomplete Reconstitution of T Cell Subsets on Combition Antiretroviral Therapy

CLINICAL INFECTIOUS DISEASES, 2009

Biomarker discovery using targeted maximum-likelihood estimation

STATISTICS IN MEDICINE, 2009

Advantages of predicted phenotypes

ANTIVIRAL THERAPY, 2009

A highly prevalent and genetically diversified Picorviridae genus in South Asian children

PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 2008

Virologic Response to Lopivir-Ritovir

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008

Minority Human Immunodeficiency Virus Type 1 Variants in Antiretroviral

JOURL OF VIROLOGY, 2008

Bayesian network alyses of resistance pathways against efavirenz and nevirapine

AIDS, 2008

Ratiol use of antiretroviral therapy in low-income and middle-income countries

AIDS, 2008

tural variation of HIV-1 group M integrase

RETROVIROLOGY, 2008

Viral population estimation using pyrosequencing

PLOS COMPUTATIOL BIOLOGY, 2008

Viral population estimation using pyrosequencing.

PLoS computatiol biology, 2008

HIV-1 drug resistance mutations: an updated framework for the second decade of HAART

AIDS REVIEWS, 2008

Sequence editing by Apolipoprotein B R-editing catalytic component-B

AIDS, 2008

Hemochromatosis gene polymorphisms, mitochondrial haplogroups

JOURL OF INFECTIOUS DISEASES, 2008

The mitochondrial pharmacogenomics of haplogroup T

PHARMACOGENOMICS JOURL, 2008

Dymics of total, linear nonintegrated, and integrated HIV-1 D in vivo and in vitro

JOURL OF INFECTIOUS DISEASES, 2008

Multiple independent origins of a protease inhibitor resistance mutation

RETROVIROLOGY, 2008

Consensus drug resistance mutations for epidemiological surveillance

ANTIVIRAL THERAPY, 2008

A highly divergent picorvirus in a marine mammal

JOURL OF VIROLOGY, 2008

Prevalence of daruvir resistance-associated mutations

JOURL OF INFECTIOUS DISEASES, 2007

World antimalarial resistance network (WARN) III: Molecular markers for drug resistant malaria

MALARIA JOURL, 2007

Educatiol attainment and response to HAART during initial therapy for HIV-1 infection

JOURL OF PSYCHOSOMATIC RESEARCH, 2007

Virologic efficacy of boosted double versus boosted single protease inhibitor therapy

AIDS, 2007

Simple PCR Assays Improve the Sensitivity of HIV-1 Subtype B Drug Resistance Testing

PLOS ONE, 2007

HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance

AIDS, 2007

Improved prediction of response to antiretroviral combition therapy using the genetic barrier to

ANTIVIRAL THERAPY, 2007

Knowledge integration of software for HIV drug resistance research.

AMIA ... Annual Symposium proceedings / AMIA Symposium. AMIA Symposium, 2007

Case files from Stanford University Medical Center: ten years of HAART

MedGenMed : Medscape general medicine, 2007

N88D facilitates the co

AIDS RESEARCH AND HUMAN RETROVIRUSES, 2006

Multilocus genetic interactions and response to efavirenz-containing regimens

PHARMACOGENET